[1]
|
Feigin, V.L., Nichols, E., Alam, T., et al. (2019) Global, Regional, and National Burden of Neurological Disorders, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18, 459-480. https://doi.org/10.1016/S1474-4422(18)30499-X
|
[2]
|
Feigin, V.L., Roth, G.A., Naghavi, M., et al. (2016) Global Burden of Stroke and Risk Factors in 188 Countries, during 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet Neurology, 15, 913-924. https://doi.org/10.1016/S1474-4422(16)30073-4
|
[3]
|
Capirossi, C., Laiso, A., Renieri, L., et al. (2023) Epidemiology, Organization, Diagnosis and Treatment of Acute Ischemic Stroke. European Journal of Radiology Open, 11, Article ID: 100527. https://doi.org/10.1016/j.ejro.2023.100527
|
[4]
|
Feigin, V.L., Stark, B.A., Johnson, C.O., et al. (2021) Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20, 795-820. https://doi.org/10.1016/S1474-4422(21)00252-0
|
[5]
|
王淑娜, 缪朝玉. 脑卒中干细胞治疗机制及临床研究进展[J]. 中国药理学与毒理学杂志, 2019, 33(2): 81-92.
|
[6]
|
Cartier, A. and Hla, T. (2019) Sphingosine 1-Phosphate: Lipid Signaling in Pathology and Therapy. Science, 366, eaar5551. https://doi.org/10.1126/science.aar5551
|
[7]
|
Aarthi, J.J., Darendeliler, M.A. and Pushparaj, P.N. (2011) Dissecting the Role of the S1P/S1PR Axis in Health and Disease. Journal of Dental Research, 90, 841-854. https://doi.org/10.1177/0022034510389178
|
[8]
|
Christoffersen, C., Obinata, H., Kumaraswamy, S.B., et al. (2011) Endothelium-Protective Sphingosine-1-Phosphate Provided by HDL-Associated Apolipoprotein M. Proceedings of the National Academy of Sciences, 108, 9613-9618. https://doi.org/10.1073/pnas.1103187108
|
[9]
|
Nitzsche, A., Poittevin, M., Benarab, A., et al. (2021) Endothelial S1P(1) Signaling Counteracts Infarct Expansion in Ischemic Stroke. Circulation Research, 128, 363-382. https://doi.org/10.1161/CIRCRESAHA.120.316711
|
[10]
|
Venkataraman, K., Lee, Y.M., Michaud, J., et al. (2008) Vascular Endothelium as a Contributor of Plasma Sphingosine 1-Phosphate. Circulation Research, 102, 669-676. https://doi.org/10.1161/CIRCRESAHA.107.165845
|
[11]
|
Argraves, K.M., Gazzolo, P.J., Groh, E.M., et al. (2008) High Density Lipoprotein-Associated Sphingosine 1-Phosphate Promotes Endothelial Barrier Function. Journal of Biological Chemistry, 283, 25074-25081. https://doi.org/10.1074/jbc.M801214200
|
[12]
|
Brinkmann, V., Billich, A., Baumruker, T., et al. (2010) Fingolimod (FTY720): Discovery and Development of an Oral Drug to Treat Multiple Sclerosis. Nature Reviews Drug Discovery, 9, 883-897. https://doi.org/10.1038/nrd3248
|
[13]
|
Zhu, X.Y., Ma, T.T., Li, Y., et al. (2023) Fingolimod Protects against Neurovascular Unit Injury in a Rat Model of Focal Cerebral Ischemia/Reperfusion Injury. Neural Regeneration Research, 18, 869-874. https://doi.org/10.4103/1673-5374.353500
|
[14]
|
Fu, Y., Zhang, N., Ren, L., et al. (2014) Impact of an Immune Modulator Fingolimod on Acute Ischemic Stroke. Proceedings of the National Academy of Sciences, 111, 18315-18320. https://doi.org/10.1073/pnas.1416166111
|
[15]
|
Kurano, M. and Yatomi, Y. (2018) Sphingosine 1-Phosphate and Atherosclerosis. Journal of Atherosclerosis and Thrombosis, 25, 16-26. https://doi.org/10.5551/jat.RV17010
|
[16]
|
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018 [J]. 中华神经科杂志, 2018, 51(9): 666-682.
|
[17]
|
Babu, M.S., Kaul, S., Dadheech, S., et al. (2013) Serum Albumin Levels in Ischemic Stroke and Its Subtypes: Correlation with Clinical Outcome. Nutrition, 29, 872-875. https://doi.org/10.1016/j.nut.2012.12.015
|
[18]
|
Bielewicz, J., Kurzepa, J., Czekajska-Chehab, E., et al. (2016) Worse Neurological State during Acute Ischemic Stroke Is Associated with a Decrease in Serum Albumin Levels. Journal of Molecular Neuroscience, 58, 493-496. https://doi.org/10.1007/s12031-015-0705-4
|
[19]
|
Dziedzic, T., Slowik, A. and Szczudlik, A. (2004) Serum Albumin Level as a Predictor of Ischemic Stroke Outcome. Stroke, 35, E156-E158. https://doi.org/10.1161/01.STR.0000126609.18735.be
|
[20]
|
Chen, J., Fredrickson, V., Ding, Y., et al. (2013) Enhanced Neuroprotection by Local Intra-Arterial Infusion of Human Albumin Solution and Local Hypothermia. Stroke, 44, 260-262. https://doi.org/10.1161/STROKEAHA.112.675462
|
[21]
|
Chen, H., Wang, J., Zhang, C., et al. (2022) Sphingosine 1-Phosphate Receptor, a New Therapeutic Direction in Different Diseases. Biomedicine & Pharmacotherapy, 153, Article ID: 113341. https://doi.org/10.1016/j.biopha.2022.113341
|
[22]
|
McGinley, M.P. and Cohen, J.A. (2021). Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis and Other Conditions. The Lancet (London, England), 398, 1184-1194. https://doi.org/10.1016/S0140-6736(21)00244-0
|
[23]
|
Soltau, I., Mudersbach, E., Geissen, M., et al. (2016) Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans. PLOS ONE, 11, e0168302. https://doi.org/10.1371/journal.pone.0168302
|
[24]
|
Liu, J., Sugimoto, K., Cao, Y., et al. (2020) Serum Sphingosine 1-Phosphate (S1P): A Novel Diagnostic Biomarker in Early Acute Ischemic Stroke. Frontiers in Neurology, 11, Article No. 985. https://doi.org/10.3389/fneur.2020.00985
|
[25]
|
Cipolla, M.J., Liebeskind, D.S. and Chan, S.L. (2018) The Importance of Comorbidities in Ischemic Stroke: Impact of Hypertension on the Cerebral Circulation. Journal of Cerebral Blood Flow & Metabolism, 38, 2129-2149. https://doi.org/10.1177/0271678X18800589
|
[26]
|
Benjamin, E.J., Virani, S.S., Callaway, C.W., et al. (2021) Heart Disease and Stroke Statistics—2018 Update: A Report from the American Heart Association. Circulation, 137, e493. https://doi.org/10.1161/CIR.0000000000000573
|
[27]
|
Tu, W.J., Wang, L.D. and Special Writing Group of China Stroke Surveillance Report (2023) China Stroke Surveillance Report 2021. Military Medical Research, 10, Article No. 33. https://doi.org/10.1186/s40779-023-00463-x
|
[28]
|
Wang, Z., Chen, Z., Zhang, L., et al. (2018) Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015. Circulation, 137, 2344-2356.
|
[29]
|
庞艳敏, 田园梦, 井丽, 等. 辽宁省农村地区40岁及以上居民脑卒中复发现况及其相关危险因素分析[J]. 中国公共卫生, 2020, 36(3): 341-345.
|
[30]
|
Baker, W.L., Marrs, J.C., Davis, L.E., et al. (2013) Key Articles and Guidelines in the Acute Management and Secondary Prevention of Ischemic Stroke. Pharmacotherapy, 33, E115-E142. https://doi.org/10.1002/phar.1252
|
[31]
|
Mitchell, A.B., Cole, J.W., McArdle, P.F., et al. (2015) Obesity Increases Risk of Ischemic Stroke in Young Adults. Stroke, 46, 1690-1692. https://doi.org/10.1161/STROKEAHA.115.008940
|
[32]
|
臧艳静, 郑宏伟, 崔泽岩. 基于血清学指标的脑梗死患者预后列线图预测模型的建立与评估[J]. 中华老年心脑血管病杂志, 2022, 24(3): 277-280.
|